Paper35106934
Critical insights to COVID-19 disease and potential treatments using a systems analysis approach that integrates physiology, pharmacology, and clinical pharmacology.
Martin JH and 1 other. Pharmacol Res Perspect, 2022. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Critical insights to COVID-19 disease and potential treatments using a systems analysis approach that integrates physiology, pharmacology, and clinical pharmacology. Papers, record 35106934. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35106934
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Critical insights to COVID-19 disease and potential treatments using a systems analysis approach that integrates physiology, pharmacology, and clinical pharmacology.
- PubMed
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| COVID-19 | Major topic |
| Pharmacology, Clinical | Major topic |
| Humans | |
| SARS-CoV-2 | |
| Systems Analysis |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment on | 35106955 | Systems analysis shows that thermodynamic physiological and pharmacological fundamentals drive COVID-19 and response to treatment. | https://conductscience.org/library/papers/35106955 |
Source PubMed
References8
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35106955 | Systems analysis shows that thermodynamic physiological and pharmacological fundamentals drive COVID-19 and response to treatment. | Pharmacol Res Perspect | 2022 | https://conductscience.org/library/papers/35106955 | PubMed |
| 2 | 34708573 | Statin withdrawal and treating COVID-19 patients. | Pharmacol Res Perspect | 2021 | https://conductscience.org/library/papers/34708573 | PubMed |
| 3 | 34708568 | Did our pharmacological strategy for COVID-19 fail? | Pharmacol Res Perspect | 2021 | https://conductscience.org/library/papers/34708568 | PubMed |
| 4 | 32895219 | Long covid: How to define it and how to manage it. | BMJ | 2020 | https://conductscience.org/library/papers/32895219 | PubMed |
| 5 | 35029046 | "LONG COVID"-A hypothesis for understanding the biological basis and pharmacological treatment strategy. | Pharmacol Res Perspect | 2022 | https://conductscience.org/library/papers/35029046 | PubMed |
| 6 | 34078498 | Obesity and COVID-19: renin-angiotensin as a mediator of morbidity and mortality. | Br J Nutr | 2022 | https://conductscience.org/library/papers/34078498 | PubMed |
| 7 | 35106954 | The interacting physiology of COVID-19 and the renin-angiotensin-aldosterone system: Key agents for treatment. | Pharmacol Res Perspect | 2022 | https://conductscience.org/library/papers/35106954 | PubMed |
| 8 | 32959913 | A pharmacological framework for integrating treating the host, drug repurposing and the damage response framework in COVID-19. | Br J Clin Pharmacol | 2021 | https://conductscience.org/library/papers/32959913 | PubMed |
Genes6
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ACE2 | 59272 | PubTator's text mining | https://conductscience.org/library/genes/59272 | NCBI Gene |
| AGT | 183 | PubTator's text mining | https://conductscience.org/library/genes/183 | NCBI Gene |
| AGTR1 | 185 | PubTator's text mining | https://conductscience.org/library/genes/185 | NCBI Gene |
| AP2B1 | 163 | PubTator's text mining | https://conductscience.org/library/genes/163 | NCBI Gene |
| NFE2L2 | 4780 | PubTator's text mining | https://conductscience.org/library/genes/4780 | NCBI Gene |
| REN | 5972 | PubTator's text mining | https://conductscience.org/library/genes/5972 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35106934
GET https://conductscience.org/api/papers/v1/35106934/authors